• For Healthcare Professionals External Link
  • Important Facts
  • IMPORTANT SAFETY INFORMATION
SUNLENCA (lenacapavir) injection 463.5 mg/1.5 mL logo
  • About SUNLENCA
    • What Is SUNLENCA?
    • How SUNLENCA Works
    • Results With SUNLENCA
  • Taking SUNLENCA
  • Safety & Side Effects
  • Support

Site Map

  • Home
  • About SUNLENCA®
    • What Is SUNLENCA?
    • How SUNLENCA Works
    • Results With SUNLENCA
  • Taking SUNLENCA
  • Safety & Side Effects
  • Support
  • IMPORTANT SAFETY INFORMATION
  • Privacy Policy
  • Terms of Use
  • Contact Us
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Contact Us
  • Consumer Health Data Privacy Policy
  • Site Map
  • Your Privacy Choices

The information contained in this site is intended for audiences in the United States only. The content on this site may not apply to non-US audiences as regulatory control, legal requirements, and/or medical practices may vary in other countries.

SUNLENCA, the SUNLENCA Logo, ADVANCING ACCESS, GILEAD, and the GILEAD Logo are trademarks of Gilead Sciences, Inc., or its related companies.

Gilead Logo

© 2026 Gilead Sciences, Inc. All rights reserved. US-SCAC-0014 04/26

You are now leaving SUNLENCA.comWould you like to continue?

Yes No